Processa Pharmaceuticals, Inc. (PCSA)
2.16
+0.10
(+4.85%)
USD |
NASDAQ |
Sep 08, 16:00
2.16
0.00 (0.00%)
Pre-Market: 20:00
Processa Pharmaceuticals Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.0042 |
| March 31, 2025 | 0.0141 |
| December 31, 2024 | 0.0433 |
| September 30, 2024 | 0.026 |
| June 30, 2024 | 0.0197 |
| March 31, 2024 | 0.0158 |
| December 31, 2023 | 0.0302 |
| September 30, 2023 | 0.0239 |
| June 30, 2023 | 0.0209 |
| March 31, 2023 | 0.0208 |
| December 31, 2022 | 0.0307 |
| September 30, 2022 | 0.0144 |
| June 30, 2022 | 0.0016 |
| March 31, 2022 | 0.0024 |
| December 31, 2021 | 0.0031 |
| September 30, 2021 | 0.0037 |
| June 30, 2021 | 0.0042 |
| March 31, 2021 | 0.0098 |
| December 31, 2020 | 0.0143 |
| September 30, 2020 | 0.3241 |
| June 30, 2020 | 0.2508 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1396 |
| December 31, 2019 | 0.1283 |
| September 30, 2019 | 0.0282 |
| June 30, 2019 | 0.0499 |
| March 31, 2019 | 0.0475 |
| December 31, 2018 | 0.02 |
| September 30, 2018 | 0.0185 |
| June 30, 2018 | 0.0171 |
| March 31, 2018 | 0.3415 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | -0.6774 |
| March 31, 2017 | -0.6615 |
| December 31, 2016 | -0.6857 |
| September 30, 2016 | -0.7167 |
| June 30, 2016 | -0.7429 |
| March 31, 2016 | -0.6527 |
| September 30, 2015 | -1.022 |
| June 30, 2015 | -1.280 |
| March 31, 2015 | 2.011 |
| December 31, 2014 | 0.7952 |
| September 30, 2014 | -21.48 |
| June 30, 2014 | 3.041 |
| March 31, 2014 | 1.588 |
| December 31, 2013 | 0.4648 |
| September 30, 2013 | 0.5034 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.070M |
| Total Liabilities (Quarterly) | 2.387M |
| Shareholders Equity (Quarterly) | -0.3173M |
| Current Ratio | 0.8657 |
| Net Debt Paydown Yield | 0.19% |